Clinical Features of BCG Lymphadenitis.
- Author:
Hyo Jin KWON
1
;
Doo Il SONG
;
Yun Kyung KIM
;
Gi Young JANG
;
Byung Min CHOI
;
Jung Hwa LEE
Author Information
1. Department of Pediatrics, College of Medicine, Korea University, Korea. byelhana@korea.ac.kr
- Publication Type:Original Article
- Keywords:
BCG vaccine;
Lymphadenitis;
Management
- MeSH:
Aspirations (Psychology);
Axilla;
BCG Vaccine;
Female;
Follow-Up Studies;
Humans;
Lymphadenitis;
Male;
Medical Records;
Mycobacterium bovis;
Needles;
Retrospective Studies;
Tokyo;
Vaccination
- From:Korean Journal of Pediatric Infectious Diseases
2009;16(1):80-86
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE:This study was performed to determine the clinical course of BCG lymphadenitis. METHODS:Between May 2005 and April 2009, the medical records of 33 patients with BCG lymphadenitis were retrospectively reviewed. If needed, needle aspiration was recommended without surgical resection or antituberculous medication. RESULTS:Of the 33 patients who were identified, 21 were males and 12 were females. Among the 33 patients, 32 were full-term babies. The mean age was 6 months (range, 2-35 months) and the most prevalent site of the lesion was the left axilla. BCG lymphadenitis was observed 1-34 months after BCG vaccination, mostly 1-6 months after vaccination. The size of the enlargement was generally 1-3 cm. The strains were identified as French (n=14), Danish (n=7), and Tokyo (n=12). BCG lymphadenitis regressed spontaneously in 19 patients. After 1-5 needle aspirations, 14 patients recovered completely. Complete regression of lymphadenitis was recorded over an average period of 4 months. CONCLUSION:Clinicians need to be aware of the clinical features of BCG lymphadenitis. For management of BCG lymphadenitis, regular follow-up with observation should be the mainstay. Needle aspiration is a safe and easy treatment for suppurative BCG lymphadenitis.
